Inhibitors of sphingosine-1-phosphate metabolism (sphingosine kinases and sphingosine-1-phosphate lyase)

Chemistry and Physics of Lipids

Volumn 197, Issue , 2016, Pages 69-81

  Sanllehí, Pol ^a,b   Abad, José Luis ^a   Casas, Josefina ^a   Delgado, Antonio ^a,b  

^a INSTITUTE OF ADVANCED CHEMISTRY OF CATALONIA IQAC CSIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Enzymes; Inhibitors; Metabolism; Modulators; Sphingolipid

Indexed keywords

3 (4 CHLOROPHENYL) N (4 PYRIDINYLMETHYL)ADAMANTANE 1 CARBOXAMIDE; BML 258; FINGOLIMOD; SPHINGOLIPID; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE INHIBITOR; SPHINGOSINE 1 PHOSPHATE LYASE; SPHINGOSINE 1 PHOSPHATE PHOSPHATASE; SPHINGOSINE DERIVATIVE; SPHINGOSINE KINASE; UNCLASSIFIED DRUG; ENZYME INHIBITOR; LYASE; PHOSPHOTRANSFERASE; SPHINGOSINE 1-PHOSPHATE LYASE (ALDOLASE);

ARTICLE; DRUG METABOLISM; ENZYME DEGRADATION; ENZYME REGULATION; ENZYME SYNTHESIS; HUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; ANIMAL; ANTAGONISTS AND INHIBITORS; METABOLISM; PHOSPHORYLATION;

ALDEHYDE-LYASES; ANIMALS; ENZYME INHIBITORS; HUMANS; PHOSPHORYLATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SPHINGOLIPIDS;

EID: 84960805152     PISSN: 00093084     EISSN: 18732941     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2015.07.007     Document Type: Article

References (147)

1. M. Adada, D. Canals, Y.A. Hannun, and L.M. Obeid Sphingosine-1-phosphate receptor 2: a review FEBS J. 280 24 2013 6354 6366
2. R. Albert, K. Hinterding, V. Brinkmann, D. Guerini, C. Müller-Hartwieg, H. Knecht, C. Simeon, M. Streiff, T. Wagner, K. Weizenbach, F. Zécri, M. Zollinger, N. Cooke, and E. Francotte Novel immunomodulator FTY720 is phosphorylated in rats and humans to form a single stereoisomer. Identification, chemical proof, and biological characterization of the biologically active species and its enantiomer J. Med. Chem. 48 2005 5373 5377
3. L. Arana, P. Gangoiti, A. Ouro, M. Trueba, and A. Gomez-Munoz Ceramide and ceramide 1-phosphate in health and disease Lipids Health Dis. 9 2010 15
4. D.J. Baek, N. MacRitchie, N.J. Pyne, S. Pyne, and R. Bittman Synthesis of selective inhibitors of sphingosine kinase 1 Chem. Commun. 49 2013 2136 2138
5. J.T. Bagdanoff, M.S. Donoviel, A. Nouraldeen, M. Carlsen, T.C. Jessop, J. Tarver, S. Aleem, L. Dong, H. Zhang, L. Boteju, J. Hazelwood, J. Yan, M. Bednarz, S. Layek, I.B. Owusu, S. Gopinathan, L. Moran, Z. Lai, J. Kramer, S.D. Kimball, P. Yalamanchili, W.E. Heydorn, K.S. Frazier, B. Brooks, P. Brown, A. Wilson, W.K. Sonnenburg, A. Main, K.G. Carson, T. Oravecz, and D.J. Augeri Inhibition of sphingosine 1-phosphate lyase for the treatment of rheumatoid arthritis: Discovery of (E)-1-(4-((1 R,2 S,3 R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl) ethanone oxime (LX2931) and (1 R,2 S,3 R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4-yl) but J. Med. Chem. 53 2010 8650 8662
6. J.T. Bagdanoff, M.S. Donoviel, A. Nouraldeen, J. Tarver, Q. Fu, M. Carlsen, T.C. Jessop, H. Zhang, J. Hazelwood, H. Nguyen, S.D. Baugh, M. Gardyan, K.M. Terranova, J. Barbosa, J. Yan, M. Bednarz, S. Layek, L.F. Courtney, J. Taylor, A.M. Digeorge-Foushee, S. Gopinathan, D. Bruce, T. Smith, L. Moran, E. O'Neill, J. Kramer, Z. Lai, S.D. Kimball, Q. Liu, W. Sun, S. Yu, J. Swaffield, A. Wilson, A. Main, K.G. Carson, T. Oravecz, and D.J. Augeri Inhibition of sphingosine-1-phosphate lyase for the treatment of autoimmune disorders J. Med. Chem. 52 2009 3941 3953
7. S. Bajjalieh, and R.J. Batchelor Ceramide Kinase 311 2000 207 215
8. P. Bandhuvula, and J.D. Saba Sphingosine-1-phosphate lyase in immunity and cancer: silencing the siren Trends Mol. Med. 13 2007 210 217
9. P. Bandhuvula, Y.Y. Tam, B. Oskouian, and J.D. Saba The immune modulator FTY720 inhibits sphingosine-1-phosphate lyase activity J. Biol. Chem. 280 2005 33697 33700
10. R. Bassi, V. Anelli, P. Giussani, G. Tettamanti, P. Viani, and L. Riboni Sphingosine-1-phosphate is released by cerebellar astrocytes in response to bFGF and induces astrocyte proliferation through Gi-protein-coupled receptors Glia 53 2006 621 630
11. E.V. Berdyshev, J. Goya, I. Gorshkova, G.D. Prestwich, H.S. Byun, R. Bittman, and V. Natarajan Characterization of sphingosine-1-phosphate lyase activity by electrospray ionization-liquid chromatography/tandem mass spectrometry quantitation of (2E)-hexadecenal Anal. Biochem. 2011 12 18
12. C. Bernacchioni, F. Cencetti, M.J. Kwon, H.S. Gwak, S.K. Jeong, P. Bruni, and C. Donati The sphingosine kinase activator K6PC-5 stimulates C2C12 myoblast differentiation Int. J. Immunopathol. Pharmacol. 24 2011 55 62
13. M. Bigaud, D. Guerini, A. Billich, F. Bassilana, and V. Brinkmann Second generation S1P pathway modulators: research strategies and clinical developments Biochim. Biophys. Acta 1841 2014 745 758
14. A. Billich, C. Beerli, R. Bergmann, C. Bruns, and E. Loetscher Cellular assay for the characterization of sphingosine-1-phosphate lyase inhibitors Anal. Biochem. 434 2013 247 253
15. A. Boath, C. Graf, E. Lidome, T. Ullrich, P. Nussbaumer, and F. Bornancin Regulation and traffic of ceramide 1-phosphate produced by ceramide kinase: Comparative analysis to glucosylceramide and sphingomyelin J. Biol. Chem. 283 2008 8517 8526
16. F. Bornancin Ceramide kinase: the first decade Cell Signal. 23 2011 999 1008
17. A. Boumendjel, and S.P.F. Miller Synthesis of an inhibitor of Sphingosine- 1-phosphate lyase Tetrahedron. Lett. 35 1994 819 822
18. F. Bourquin, H. Riezman, G. Capitani, and M.G. Grutter Structure and function of sphingosine-1-phosphate lyase, a key enzyme of sphingolipid metabolism Structure 18 2010 1054 1065
19. D.N. Brindley Lipid phosphate phosphatases and related proteins: Signaling functions in development, cell division, and cancer J. Cell. Biochem. 92 2004 900 912
20. V. Brinkmann, A. Billich, T. Baumruker, P. Heining, R. Schmouder, G. Francis, S. Aradhye, and P. Burtin Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis Nat. Rev. Drug Discov. 9 2010 883 897
21. B.M. Buehrer, and R.M. Bell Inhibition of sphingosine kinase in vitro and in platelets. Implications for signal transduction pathways J. Biol. Chem. 267 1992 3154 3159
22. H.-S. Byun, S. Pyne, N. MacRitchie, N.J. Pyne, and R. Bittman Novel sphingosine-containing analogues selectively inhibit sphingosine kinase (SK) isozymes, induce SK1 proteasomal degradation and reduce DNA synthesis in human pulmonary arterial smooth muscle cells MedChemComm 4 2013 1394 1399
23. S.M. Cahalan Chemical and genetic tools to explore S1P biology Curr. Top. Microbiol. Immunol. 378 2014 55 83
24. 1-eGFP knock-in mice Nat. Chem. Biol. 7 2011 254 256
25. D. Canals, D. Mormeneo, G. Fabriàs, A. Llebaria, J. Casas, and A. Delgado Synthesis and biological properties of Pachastrissamine (jaspine B) and diastereoisomeric jaspines Bioorg. Med. Chem. 17 2009 235 241
26. A. Carre, C. Graf, S. Stora, D. Mechtcheriakova, R. Csonga, N. Urtz, A. Billich, T. Baumruker, and F. Bornancin Ceramide kinase targeting and activity determined by its N-terminal pleckstrin homology domain Biochem. Biophys. Res. Commun. 324 2004 1215 1219
27. M.-H. Chen, C.-C. Yen, C.-T. Cheng, R.-C. Wu, S.-C. Huang, C.-S. Yu, Y.-H. Chung, C.-Y. Liu, P.M.-H. Chang, Y. Chao, M.-H. Chen, Y.-F. Chen, K.-C. Chiang, T.-S. Yeh, T.C. Chen, C.-Y.F. Huang, and C.-N. Yeh Identification of SPHK1 as a Therapeutic Target and Marker of Poor Prognosis in Cholangiocarcinoma 2015 Oncotarget
28. F. Cingolani, M. Casasampere, P. Sanllehí, J. Casas, J. Bujons, and G. Fabrias Inhibition of dihydroceramide desaturase activity by the sphingosine kinase inhibitor SKI II J. Lipid Res. 55 2014 1711 1720
29. S. Cosconati, E. Novellino, S. Universita, and V. Vivaldi The first sphingosine 1-phosphate lyase inhibitors against multiple sclerosis: a successful drug discovery tale J. Med. Chem. 57 2014 5072 5073
30. J. Coward, G. Ambrosini, E. Musi, J.P. Truman, A. Haimovitz-Friedman, J.C. Allegood, E. Wang, A.H. Merrill Jr, and G.K. Schwartz Safingol (L-threo-sphinganine) induces autophagy in solid tumor cells through inhibition of PKC and the PI3-kinase pathway Autophagy 5 2009 184 193
31. R. Cuadros, E. Montejo de Garcini, F. Wandosell, G. Faircloth, J.M. Fernandez-Sousa, and J. Avila The marine compound spisulosine, an inhibitor of cell proliferation, promotes the disassembly of actin stress fibers Cancer Lett. 152 2000 23 29
32. R. Cuadros, E. Montejo, F. Wendosell, G.T. Faircloth, J. Luber-Narod, J.M. Jimeno, J.M. Fernandez-Sousa, and J. Avila The effects of spisulosine (es-285), a marine natural product, on the morphology and survival of tumor cells Clin. Cancer Res. 6 2000 220
33. O. Cuvillier Sphingosine 1-phosphate receptors: from biology to physiopathology Med. Sci. (Paris) 28 2012 951 957
34. O. Cuvillier, G. Pirianov, B. Kleuser, P.G. Vanek, O.A. Coso, S. Gutkind, and S. Spiegel Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate Nature 381 1996 800 803
35. M.D. Davis, J.J. Clemens, T.L. Macdonald, and K.R. Lynch Sphingosine 1-phosphate analogs as receptor antagonists J. Biol. Chem. 280 2005 9833 9841
36. G. Fabrias, J. Muñoz-Olaya, F. Cingolani, P. Signorelli, J. Casas, V. Gagliostro, R. Ghidoni, J. Muñoz-Olaya, F. Cingolani, P. Signorelli, J. Casas, V. Gagliostro, and R. Ghidoni Dihydroceramide desaturase and dihydrosphingolipids: debutant players in the sphingolipid arena Prog. Lipid Res. 51 2012 82 94
37. Foss Jr, FW, A.H. Snyder, M.D. Davis, M. Rouse, M.D. Okusa, K.R. Lynch, and T.L. Macdonald Synthesis and biological evaluation of gamma-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists Bioorg. Med. Chem. 15 2007 663 677
38. K.J. French, R.S. Schrecengost, B.D. Lee, Y. Zhuang, S.N. Smith, J.L. Eberly, J.K. Yun, and C.D. Smith Discovery and evaluation of inhibitors of human sphingosine kinase Cancer Res. 63 2003 5962 5969
39. K.J. French, J.J. Upson, S.N. Keller, Y. Zhuang, J.K. Yun, and C.D. Smith Antitumor activity of sphingosine kinase inhibitors J. Pharmacol. Exp. Ther. 318 2006 596 603
40. K.J. French, Y. Zhuang, L.W. Maines, P. Gao, W. Wang, V. Beljanski, J.J. Upson, C.L. Green, S.N. Keller, and C.D. Smith Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2 J. Pharmacol. Exp. Ther. 333 2010 129 139
41. R.M. Fryer, A. Muthukumarana, P.C. Harrison, S. Nodop Mazurek, R.R. Chen, K.E. Harrington, R.M. Dinallo, J.C. Horan, L. Patnaude, L.K. Modis, and G.A. Reinhart The clinically-tested S1P receptor agonists, FTY720 and BAF312, demonstrate subtype-specific bradycardia (S1P1) and hypertension (S1P3) in rat PLoS ONE 7 2012 e52985
42. Y. Fujii, T. Hirayama, H. Ohtake, N. Ono, T. Inoue, T. Sakurai, T. Takayama, K. Matsumoto, N. Tsukahara, S. Hidano, N. Harima, K. Nakazawa, Y. Igarashi, and R. Goitsuka Amelioration of Collagen-Induced Arthritis by a Novel S1P1 Antagonist with Immunomodulatory Activities J. Immunol. 188 2011 206 215
43. H. Fyrst, and J.D. Saba An update on sphingosine-1-phosphate and other sphingolipid mediators Nat. Chem. Biol. 6 2010 489 497
44. P. Gangoiti, L. Camacho, L. Arana, A. Ouro, M.H. Granado, L. Brizuela, J. Casas, G. Fabriás, J.L. Abad, A. Delgado, and A. Gómez-Muñoz Control of metabolism and signaling of simple bioactive sphingolipids: implications in disease Prog. Lipid Res. 49 2010 316 334
45. J. Gatfield, L. Monnier, R. Studer, M.H. Bolli, B. Steiner, and O. Nayler Sphingosine-1-phosphate (S1P) displays sustained S1P1 receptor agonism and signaling through S1P lyase-dependent receptor recycling Cell. Signal. 26 2014 1576 1588
46. A. Gomez-Munoz, P. Gangoiti, L. Arana, A. Ouro, I.G. Rivera, M. Ordonez, and M. Trueba New insights on the role of ceramide 1-phosphate in inflammation Biochim. Biophys. Acta 1831 2013 1060 1066
47. P.J. Gonzalez-Cabrera, E. Jo, M.G. Sanna, S. Brown, N. Leaf, D. Marsolais, M.T. Schaeffer, J. Chapman, M. Cameron, M. Guerrero, E. Roberts, and H. Rosen Full pharmacological efficacy of a novel S1P1 agonist that does not require S1P-like head-group interactions Mol. Pharmacol. 74 2008 1308 1318
48. M.H. Granado, P. Gangoiti, A. Ouro, L. Arana, M. González, M. Trueba, and A. Gómez-Muñoz Ceramide 1-phosphate (C1P) promotes cell migration: involvement of a specific C1P receptor Cell. Signal. 21 2009 405 412
49. M. Guerrero, R. Poddutoori, M. Urbano, X. Peng, T.P. Spicer, P.S. Chase, P.S. Hodder, M.-T. Schaeffer, S. Brown, H. Rosen, and E. Roberts Discovery, design and synthesis of a selective S1P(3) receptor allosteric agonist Bioorg. Med. Chem. Lett. 23 2013 6346 6349
50. 4-R) agonists Bioorg. Med. Chem. Lett. 22 2012 537 542
51. R. Gugasyan, Coward a, L. O'Connor, K. Shortman, and R. Scollay Emigration of mature T cells from the thymus is inhibited by the imidazole-based compound 2-acetyl-4-tetrahydroxybutylimidazole Immunology 93 1998 398 404
52. D.J. Gustin, Y. Li, M.L. Brown, X. Min, M.J. Schmitt, M. Wanska, X. Wang, R. Connors, S. Johnstone, M. Cardozo, A.C. Cheng, S. Jeffries, B. Franks, S. Li, S. Shen, M. Wong, H. Wesche, G. Xu, T.J. Carlson, M. Plant, K. Morgenstern, K. Rex, J. Schmitt, A. Coxon, N. Walker, F. Kayser, and Z. Wang Structure guided design of a series of sphingosine kinase (SphK) inhibitors Bioorg. Med. Chem. Lett. 23 2013 4608 4616
53. P. Hänel, Andréani, P. Gräler, and MH Erythrocytes store and release sphingosine 1-phosphate in blood FASEB J. 21 2007 1202 1209
54. Y.A. Hannun, and L.M. Obeid Many ceramides J. Biol. Chem. 286 2011 27855 27862
55. Y.A. Hannun, and L.M. Obeid Principles of bioactive lipid signalling: lessons from sphingolipids Nat. Rev. Mol. Cell. Biol. 9 2008 139 150
56. M.A. Hanson, C.B. Roth, E. Jo, M.T. Griffith, F.L. Scott, G. Reinhart, H. Desale, B. Clemons, S.M. Cahalan, S.C. Schuerer, M.G. Sanna, G.W. Han, P. Kuhn, H. Rosen, and R.C. Stevens Crystal structure of a lipid G protein-coupled receptor Science 335 2012 851 855
57. M. Hara-Yokoyama, K. Terasawa, S. Ichinose, A. Watanabe, K.A. Podyma-Inoue, K. Akiyoshi, Y. Igarashi, and M. Yanagishita Sphingosine kinase 2 inhibitor SG-12 induces apoptosis via phosphorylation by sphingosine kinase 2 Bioorg. Med. Chem. Lett. 23 2013 2220 2224
58. Hengst, J. a. Wang, X. Sk, U.H. Sharma, A.K. Amin, S. Yun, and JK Development of a sphingosine kinase 1 specific small-molecule inhibitor Bioorg. Med. Chem. Lett. 20 2010 7498 7502
59. Y. Igarashi, S. Hakomori, T. Toyokuni, B. Dean, S. Fujita, M. Sugimoto, T. Ogawa, K. el-Ghendy, and E. Racker Effect of chemically well-defined sphingosine and its N-methyl derivatives on protein kinase C and src kinase activities Biochemistry 28 1989 6796 6800
60. M. Ikeda, A. Kihara, and Y. Igarashi Sphingosine-1-phosphate lyase SPL is an endoplasmic reticulum-resident, integral membrane protein with the pyridoxal 5′-phosphate binding domain exposed to the cytosol Biochem. Biophys. Res. Commun. 325 2004 338 343
61. F. Ji, M. Li, Y. Liu, X. Cao, Y. Xie, S. Wang, and H. Fei K6PC-5, a novel sphingosine kinase 1 (SphK1) activator, alleviates dexamethasone-induced damages to osteoblasts through activating SphK1-Akt signaling Biochem. Biophys. Res. Commun. 1 2015 1 8
62. E. Jo, B. Bhhatarai, E. Repetto, M. Guerrero, S. Riley, S.J. Brown, Y. Kohno, E. Roberts, S.C. Schürer, and H. Rosen Novel selective allosteric and bitopic ligands for the S1P3 receptor ACS Chem. Biol. 7 2012 1975 1983
63. E. Jo, M.G. Sanna, P.J. Gonzalez-Cabrera, S. Thangada, G. Tigyi, D.A. Osborne, T. Hla, A.L. Parrill, and H. Rosen S1P(1)-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and Ffate Chem. Biol. 12 2005 703 715
64. Y. Kharel, T.P. Mathews, A.M. Gellett, J.L. Tomsig, P.C. Kennedy, M.L. Moyer, T.L. Macdonald, and K.R. Lynch Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphate Biochem. J. 440 2011 345 353
65. Y. Kharel, M. Raje, M. Gao, A.M. Gellett, J.L. Tomsig, K.R. Lynch, and W.L. Santos Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate Biochem. J. 447 2012 149 157
66. A. Kihara, S. Mitsutake, Y. Mizutani, and Y. Igarashi Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate Prog. Lipid Res. 46 2007 126 144
67. J.W. Kim, Y.W. Kim, Y. Inagaki, Y.A. Hwang, S. Mitsutake, Y.W. Ryu, W.K. Lee, H.J. Ha, C.S. Park, and Y. Igarashi Synthesis and evaluation of sphingoid analogs as inhibitors of sphingosine kinases Bioorg. Med. Chem. 13 2005 3475 3485
68. M. Ksiazek, M. Chacińska, A. Chabowski, and M. Baranowski Sources, metabolism, and regulation of circulating sphingosine-1-phosphate J. Lipid Res. 56 2015 1271 1281
69. K. Kumagai, S. Yasuda, K. Okemoto, M. Nishijima, S. Kobayashi, and K. Hanada CERT mediates intermembrane transfer of various molecular species of ceramides J. Biol. Chem. 280 2005 6488 6495
70. I. Kuroda, M. Musman, I.I. Ohtani, T. Ichiba, J. Tanaka, D.G. Gravalos, and T. Higa Pachastrissamine, a cytotoxic anhydrophytosphingosine from a marine sponge, Pachastrissa sp J. Nat. Prod. 65 2002 1505 1506
71. K. Kusumi, K. Shinozaki, T. Kanaji, H. Kurata, A. Naganawa, K. Otsuki, T. Matsushita, T. Sekiguchi, A. Kakuuchi, and T. Seko Discovery of novel S1P2 antagonists, part 1: discovery of 1,3-bis(aryloxy) benzene derivatives Bioorg. Med. Chem. Lett. 2015 29 32
72. Y.B. Kwon, C.D. Kim, J.K. Youm, H.S. Gwak, B.D. Park, S.H. Lee, S. Jeon, B.J. Kim, Y.J. Seo, J.K. Park, and J.H. Lee Novel synthetic ceramide derivatives increase intracellular calcium levels and promote epidermal keratinocyte differentiation J. Lipid Res. 48 2007 1936 1943
73. V. Ledroit, C. Debitus, C. Lavaud, and G. Massiot Jaspines A and B: two new cytotoxic sphingosine derivatives from the marine sponge Jaspis sp Tetrahedr. Lett. 44 2003 225 228
74. K.G. Lim, C. Sun, R. Bittman, N.J. Pyne, and S. Pyne (R)-FTY720 methyl ether is a specific sphingosine kinase 2 inhibitor: Effect on sphingosine kinase 2 expression in HEK 293 cells and actin rearrangement and survival of MCF-7 breast cancer cells Cell Signal 23 2011 1590 1595
75. K.G. Lim, F. Tonelli, Z. Li, X. Lu, R. Bittman, S. Pyne, and N.J. Pyne FTY720 analogues as sphingosine kinase 1 inhibitors: enzyme inhibition kinetics, allosterism, proteasomal degradation and actin rearrangement in MCF-7 breast cancer cells J. Biol. Chem. 286 2011 18633 18640
76. H. Liu, M. Sugiura, V.E. Nava, L.C. Edsall, K. Kono, S. Poulton, S. Milstien, T. Kohama, and S. Spiegel Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform J. Biol. Chem. 275 2000 19513 19520
77. K. Liu, T.L. Guo, N.C. Hait, J. Allegood, H.I. Parikh, W. Xu, G.E. Kellogg, S. Grant, S. Spiegel, and S. Zhang Biological characterization of 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) as a selective sphingosine kinase-2 inhibitor and anticancer agent PLoS ONE 8 2013 e56471
78. Z. Liu, N. MacRitchie, S. Pyne, N.J. Pyne, and R. Bittman Synthesis of (S)-FTY720 vinylphosphonate analogues and evaluation of their potential as sphingosine kinase 1 inhibitors and activators Bioorg. Med. Chem. 21 2013 2503 2510
79. E. Loetscher, K. Schneider, C. Beerli, and A. Billich Assay to measure the secretion of sphingosine-1-phosphate from cells induced by S1P lyase inhibitors Biochem. Biophys. Res. Commun. 433 2013 345 348
80. M. Maceyka, H. Sankala, N.C. Hait, H. Le Stunff, H. Liu, R. Toman, C. Collier, M. Zhang, L. Satin, A.H. Merrill Jr, S. Milstien, and S. Spiegel Sphk1 and Sphk2: Sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism J. Biol. Chem. 280 2005 37118 37129
81. M. Maceyka, and S. Spiegel Sphingolipid metabolites in inflammatory disease Nature 510 2014 58 67
82. L.W. Maines, L.R. Fitzpatrick, C.L. Green, Y. Zhuang, and C.D. Smith Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn's disease Inflammopharmacology 18 2010 73 85
83. M. Matloubian, C.G. Lo, G. Cinamon, M.J. Lesneski, Y. Xu, V. Brinkmann, M.L. Allende, R.L. Proia, and J.G. Cyster Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1 Nature 427 2004 355 360
84. Q. Meng, B. Zhao, Q. Xu, X. Xu, G. Deng, C. Li, L. Luan, F. Ren, H. Wang, H. Xu, Y. Xu, H. Zhang, J.-N. Xiang, J.D. Elliott, T.B. Guo, Y. Zhao, W. Zhang, H. Lu, and X. Lin Indole-propionic acid derivatives as potent, S1P3-sparing and EAE efficacious sphingosine-1-phosphate 1 (S1P1) receptor agonists Bioorg. Med. Chem. Lett. 22 2012 2794 2797
85. A.H. Merrill Jr., S. Nimkar, D. Menaldino, Y.A. Hannun, C. Loomis, R.M. Bell, S.R. Tyagi, J.D. Lambeth, V.L. Stevens, R. Hunter, and et al. Structural requirements for long-chain (sphingoid) base inhibition of protein kinase C in vitro and for the cellular effects of these compounds Biochemistry 28 1989 3138 3145
86. P. Mitra, C.A. Oskeritzian, S.G. Payne, M.A. Beaven, S. Milstien, and S. Spiegel Role of ABCC1 in export of sphingosine-1-phosphate from mast cells Proc. Natl. Acad. Sci. U. S. A. 103 2006 16394 16399
87. K. Mizugishi, T. Yamashita, A. Olivera, G.F. Miller, S. Spiegel, and R.L. Proia Essential role for sphingosine kinases in neural and vascular development Mol. Cell. Biol. 25 2005 11113 11121
88. T.D. Mullen, Y.A. Hannun, and L.M. Obeid Ceramide synthases at the centre of sphingolipid metabolism and biology Biochem. J. 441 2012 789 802
89. A. Murakami, H. Takasugi, S. Ohnuma, Y. Koide, A. Sakurai, S. Takeda, T. Hasegawa, J. Sasamori, T. Konno, K. Hayashi, Y. Watanabe, K. Mori, Y. Sato, A. Takahashi, and N. Mochizuki Sphingosine 1-phosphate (S1P) regulates vascular contraction via S1P 3 receptor: investigation based on a new S1P 3 receptor antagonist Mol. Pharmacol. 77 2010 704 713
90. T. Nakamura, M. Asano, Y. Sekiguchi, Y. Mizuno, K. Tamaki, T. Kimura, F. Nara, Y. Kawase, T. Shimozato, H. Doi, T. Kagari, W. Tomisato, R. Inoue, M. Nagasaki, H. Yuita, K. Oguchi-Oshima, R. Kaneko, N. Watanabe, Y. Abe, and T. Nishi Discovery of CS-2100, a potent, orally active and S1P3-sparing S1P1 agonist Bioorg. Med. Chem. Lett. 22 2012 1788 1792
91. H.A. Neubauer, and S.M. Pitson Roles, regulation and inhibitors of sphingosine kinase 2 FEBS J. 280 2013 5317 5336
92. J. Newton, S. Lima, M. Maceyka, and S. Spiegel Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy Exp. Cell Res. 333 2015 195 200
93. M. Ohtoyo, M. Tamura, N. Machinaga, F. Muro, and R. Hashimoto Sphingosine 1-phosphate lyase inhibition by 2-acetyl-4-(tetrahydroxybutyl) imidazole (THI) under conditions of vitamin B6 deficiency Mol. Cell. Biochem. 400 2015 125 133
94. Oldstone, M., Hodder, P., Crisp, M., Roberts, E., Guerrero, M., Urbano, M., Velaparthi, S., Zhao, J., Rosen, H., Schaeffer, M.T., Brown, S., Ferguson, J., 2010. Probe Development Efforts to Identify Novel Antagonists of the Sphingosine 1-phosphate Receptor 4 (S1P4) - PubMed - NCBI [WWW Document]. Probe Reports from NIH Mol. Libr. Progr. [Internet]. Bethesda Natl. Cent. Biotechnol. Inf. (US); 2010. http://www.ncbi.nlm.nih.gov/pubmed/21433398 (accessed 04.24.15.).
95. K.A. Orr Gandy, and L.M. Obeid Targeting the sphingosine kinase/sphingosine 1-phosphate pathway in disease: Review of sphingosine kinase inhibitors Biochim. Biophys. Acta 1831 2013 157 166
96. M. Osada, Y. Yatomi, T. Ohmori, H. Ikeda, and Y. Ozaki Enhancement of sphingosine 1-phosphate-induced migration of vascular endothelial cells and smooth muscle cells by an EDG-5 antagonist Biochem. Biophys. Res. Commun. 299 2002 483 487
97. S. Pan, Mi, Y. Pally, C. Beerli, C. Chen, A. Guerini, D. Hinterding, K. Nuesslein-Hildesheim, B. Tuntland, T. Lefebvre, S. Liu, Y. Gao, W. Chu, A. Brinkmann, V. Bruns, C. Streiff, M. Cannet, C. Cooke, N. Gray, and N A monoselective sphingosine-1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation model Chem. Biol. 13 2006 1227 1234
98. H.Y. Park, J.-K.K. Youm, M.J. Kwon, B.D. Park, S.H. Lee, and E.H. Choi K6PC-5, a novel sphingosine kinase activator, improves long-term ultraviolet light-exposed aged murine skin Exp. Dermatol. 17 2008 829 836
99. N.N. Patwardhan, E. Morris a, Y. Kharel, M.R. Raje, M. Gao, J.L. Tomsig, K.R. Lynch, and W.L. Santos Structure-Activity Relationship Studies and in Vivo Activity of Guanidine-Based Sphingosine Kinase Inhibitors: Discovery of SphK1- and SphK2-Selective Inhibitors J. Med. Chem. 58 2015 1879 1899
100. S.W. Paugh, B.S. Paugh, M. Rahmani, D. Kapitonov, J.A. Almenara, T. Kordula, S. Milstien, J.K. Adams, R.E. Zipkin, S. Grant, and S. Spiegel A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia Blood 112 2008 1382 1391
101. S.W. Paugh, S.G. Payne, S.E. Barbour, S. Milstien, and S. Spiegel The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2 FEBS Lett. 554 2003 189 193
102. B.J. Pettus, A. Bielawska, S. Spiegel, P. Roddy, Y.A. Hannun, and C.E. Chalfant Ceramide kinase mediates cytokine- and calcium ionophore-induced arachidonic acid release J. Biol. Chem. 278 2003 38206 38213
103. B.J. Pettus, A. Bielawska, P. Subramanian, D.S. Wijesinghe, M. Maceyka, C.C. Leslie, J.H. Evans, J. Freiberg, P. Roddy, Y.A. Hannun, and C.E. Chalfant Ceramide 1-phosphate is a direct activator of cytosolic phospholipase A(2) J. Biol. Chem. 279 2004 11320 11326
104. M.R. Pitman, and S.M. Pitson Inhibitors of the sphingosine kinase pathway as potential therapeutics Curr. Cancer Drug Targets 10 2010 354 367
105. M.R. Pitman, J.A. Powell, C. Coolen, P.A.B. Moretti, J.R. Zebol, D.H. Pham, J.W. Finnie, A.S. Don, L.M. Ebert, C.S. Bonder, B.L. Gliddon, and S.M. Pitson A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties Oncotarget 2015
106. D. Plano, S.G. Amin, and A.K. Sharma Importance of Sphingosine Kinase (SphK) as a Target in Developing Cancer Therapeutics and Recent Developments in the Synthesis of Novel SphK Inhibitors J. Med. Chem. 57 2014 5509 5524
107. M.J. Pulkoski-Gross, J.C. Donaldson, and L.M. Obeid Sphingosine-1-phosphate metabolism: A structural perspective Crit. Rev. Biochem. Mol. Biol. 00 2015 10.3109/10409238.2015.1039115
108. S. Pyne, R. Bittman, and N.J. Pyne Sphingosine kinase inhibitors and cancer: seeking the golden sword of hercules Cancer Res. 71 2011 6576 6582
109. S. Pyne, K.-C. Kong, and P.I. Darroch Lysophosphatidic acid and sphingosine 1-phosphate biology: the role of lipid phosphate phosphatases Semin. Cell Dev. Biol. 15 2004 491 501
110. J. Quancard, B. Bollbuck, P. Janser, D. Angst, F. Berst, P. Buehlmayer, M. Streiff, C. Beerli, V. Brinkmann, D. Guerini, P. Smith a, T.J. Seabrook, M. Traebert, K. Seuwen, R. Hersperger, C. Bruns, F. Bassilana, and M. Bigaud A potent and selective S1P1 antagonist with efficacy in experimental autoimmune encephalomyelitis Chem. Biol. 19 2012 1142 1151
111. M.R. Raje, K. Knott, Y. Kharel, P. Bissel, K.R. Lynch, and W.L. Santos Design, synthesis and biological activity of sphingosine kinase 2 selective inhibitors Bioorg. Med. Chem. 20 2012 183 194
112. K. Rex, S. Jeffries, M.L. Brown, T. Carlson, A. Coxon, F. Fajardo, B. Frank, D. Gustin, A. Kamb, P.D. Kassner, S. Li, Y. Li, K. Morgenstern, M. Plant, K. Quon, A. Ruefli-Brasse, J. Schmidt, E. Swearingen, N. Walker, Z. Wang, J.E.V. Watson, D. Wickramasinghe, M. Wong, G. Xu, and H. Wesche Sphingosine Kinase Activity Is Not Required for Tumor Cell Viability PLoS ONE 8 2013 e68328
113. E. Roberts, M. Guerrero, M. Urbano, and H. Rosen Sphingosine 1-phosphate receptor agonists: a patent review (2010-2012) Exp. Opin. Ther. Pat. 23 2013 817 841
114. H. Rosen, R.C. Stevens, M. Hanson, E. Roberts, and M.B.A. Oldstone Sphingosine-1-phosphate and its receptors: structure, signaling, and influence Annu. Rev. Biochem. 82 2013 637 662
115. Y. Salma, S. Ballereau, S. Ladeira, C. Lepetit, R. Chauvin, N. Andrieu-Abadie, and Y. Genisson Single- and double-chained truncated jaspine B analogues: asymmetric synthesis, biological evaluation and theoretical study of an unexpected 5-endo-dig process Tetrahedron 67 2011 4253 4262
116. Y. Salma, S. Ballereau, S. Ladeira, C. Lepetit, R. Chauvin, N. Andrieu-Abadie, and Y. Génisson Corrigendum to Single- and double-chained truncated jaspine B analogues: asymmetric synthesis, biological evaluation and theoretical study of an unexpected 5-endo-dig process [Tetrahedron 67 (2011) 4253-4262] Tetrahedron 68 2012 1819
117. Y. Salma, E. Lafont, N. Therville, S. Carpentier, M.J. Bonnafe, T. Levade, Y. Genisson, and N. Andrieu-Abadie The natural marine anhydrophytosphingosine, Jaspine B, induces apoptosis in melanoma cells by interfering with ceramide metabolism Biochem. Pharmacol. 78 2009 477 485
118. T. Sanchez, and T. Hla Structural and functional characteristics of S1P receptors J. Cell. Biochem. 92 2004 913 922
119. W.L. Santos, and K.R. Lynch Drugging Sphingosine Kinases ACS Chem. Biol. 10 2015 225 233
120. H. Satsu, M.-T. Schaeffer, M. Guerrero, A. Saldana, C. Eberhart, P. Hodder, C. Cayanan, S. Schürer, B. Bhhatarai, E. Roberts, H. Rosen, and S.J. Brown A sphingosine 1-phosphate receptor 2 selective allosteric agonist Bioorg. Med. Chem. 21 2013 5373 5382
121. M.E. Schnute, M.D. McReynolds, T. Kasten, M. Yates, G. Jerome, J.W. Rains, T. Hall, J. Chrencik, M. Kraus, C.N. Cronin, M. Saabye, M.K. Highkin, R. Broadus, S. Ogawa, K. Cukyne, L.E. Zawadzke, V. Peterkin, K. Iyanar, J.A. Scholten, J. Wendling, H. Fujiwara, O. Nemirovskiy, A.J. Wittwer, and M.M. Nagiec Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1 Biochem. J. 444 2012 79 88
122. J. Schumann, A. Grevot, D. Ledieu, A. Wolf, A. Schubart, A. Piaia, E. Sutter, S. Cote, C. Beerli, F. Pognan, A. Billich, P. Moulin, and U.J. Walker Reduced activity of sphingosine-1-phosphate lyase induces podocyte-related glomerular proteinuria, skin irritation, and platelet activation Toxicol. Pathol. 2015
123. S.R. Schwab, J.P. Pereira, M. Matloubian, Y. Xu, Y. Huang, and J.G. Cyster Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients Science 309 2005 1735 1739
124. J. Skidmore, J. Heer, C.N. Johnson, D. Norton, S. Redshaw, J. Sweeting, D. Hurst, A. Cridland, D. Vesey, I. Wall, M. Ahmed, D. Rivers, J. Myatt, G. Giblin, K. Philpott, U. Kumar, A. Stevens, R.A. Bit, A. Haynes, S. Taylor, R. Watson, J. Witherington, E. Demont, and T.D. Heightman Optimization of Sphingosine-1-phosphate-1 Receptor Agonists: Effects of Acidic, Basic, and Zwitterionic Chemotypes on Pharmacokinetic and Pharmacodynamic Profiles J. Med. Chem. 57 2014 10424 10442
125. J. Song, C. Matsuda, Y. Kai, T. Nishida, K. Nakajima, T. Mizushima, M. Kinoshita, T. Yasue, Y. Sawa, and T. Ito A novel sphingosine 1-phosphate receptor agonist, 2-amino-2-propanediol hydrochloride (KRP-203), regulates chronic colitis in interleukin-10 gene-deficient mice J. Pharmacol. Exp. Ther. 324 2008 276 283
126. S. Spiegel, and S. Milstien The outs and the ins of sphingosine-1-phosphate in immunity Nat. Rev. Immunol. 11 2011 403 415
127. S. Spiegel, and S. Milstien Sphingosine-1-phosphate: an enigmatic signalling lipid Nat. Rev. Mol. Cell. Biol. 4 2003 397 407
128. W. Stoffel, and M. Grol Chemistry and biochemistry of 1-desoxysphinganine-1-phosphonate (dihydrosphingosine-1-phosphonate) Chem. Phys. Lipids 13 1974 372 388
129. C.R. Strader, C.J. Pearce, and N.H. Oberlies Fingolimod (FTY720): a recently approved multiple sclerosis drug based on a fungal secondary metabolite J. Nat. Prod. 74 2011 900 907
130. G.M. Strub, M. Paillard, J. Liang, L. Gomez, J.C. Allegood, N.C. Hait, M. Maceyka, M.M. Price, Q. Chen, D.C. Simpson, T. Kordula, S. Milstien, E.J. Lesnefsky, and S. Spiegel Sphingosine-1-phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration FASEB J. 25 2011 600 612
131. G. Tarrason, M. Auli, S. Mustafa, V. Dolgachev, M.T. Domenech, N. Prats, M. Dominguez, R. Lopez, N. Aguilar, M. Calbet, M. Pont, G. Milligan, S.L. Kunkel, and N. Godessart The sphingosine-1-phosphate receptor-1 antagonist, W146, causes early and short-lasting peripheral blood lymphopenia in mice Int. Immunopharmacol. 11 2011 1773 1779
132. M. Urbano, M. Guerrero, J. Zhao, S. Velaparthi, M.T. Schaeffer, S. Brown, H. Rosen, and E. Roberts SAR analysis of innovative selective small molecule antagonists of sphingosine-1-phosphate 4 (S1P) receptor Bioorg. Med. Chem. Lett. 21 2011 5470 5474
133. W.J. Valentine, G.N. Kiss, J. Liu, S. E, M. Gotoh, K. Murakami-Murofushi, T.C. Pham, D.L. Baker, A.L. Parrill, X. Lu, C. Sun, R. Bittman, N.J. Pyne, and G. Tigyi S)-FTY720-Vinylphosphonate, an analogue of the immunosuppressive agent FTY720, is a pan-antagonist of sphingosine 1-phosphate GPCR signaling and inhibits autotaxin activity Cell. Signal. 22 2010 1543 1553
134. H. Van Overloop, S. Gijsbers, and P.P. Van Veldhoven Further characterization of mammalian ceramide kinase: substrate delivery and (stereo) specificity, tissue distribution, and subcellular localization studies J. Lipid Res. 47 2006 268 283
135. P.P. Van Veldhoven, S. Gijsbers, G.P. Mannaerts, J.R. Vermeesch, and V. Brys Human sphingosine-1-phosphate lyase: cDNA cloning, functional expression studies and mapping to chromosome 10q22(1) Biochim. Biophys. Acta 1487 2000 128 134
136. J. Wang, S. Knapp, N.J. Pyne, S. Pyne, and J.M. Elkins Crystal Structure of Sphingosine Kinase 1 with PF-543 ACS Med. Chem. Lett. 5 2014 1329 1333
137. Z. Wang, X. Min, S.-H. Xiao, S. Johnstone, W. Romanow, D. Meininger, H. Xu, J. Liu, J. Dai, S. An, S. Thibault, and N. Walker Molecular basis of sphingosine kinase 1 substrate recognition and catalysis Structure 21 2013 http://dx.doi.org/10.1016/j.str.2013.02.025
138. S. Weiler, N. Braendlin, C. Beerli, C. Bergsdorf, A. Schubart, H. Srinivas, B. Oberhauser, and A. Billich Orally active 7-substituted (4-benzyl-phthalazin-1-yl)-2-methyl-piperazin-1-yl]-nicotinonitriles as active-site inhibitors of sphingosine-1-phosphate lyase for the treatment of multiple sclerosis J. Med. Chem. 57 2014 5074 5084
139. T. Wennekes, R.J. van den Berg, R.G. Boot, G.A. van der Marel, H.S. Overkleeft, and J.M. Aerts Glycosphingolipids - nature, function, and pharmacological modulation Angew. Chem. Int. Ed. Engl. 48 2009 8848 8869
140. L. Wong, S.S. Tan, Y. Lam, and A.J. Melendez Synthesis and evaluation of sphingosine analogues as inhibitors of sphingosine kinases J. Med. Chem. 52 2009 3618 3626
141. Y. Xiang, G. Asmussen, M. Booker, B. Hirth, J.L. Kane Jr, J. Liao, K.D. Noson, and C. Yee Discovery of novel sphingosine kinase 1 inhibitors Bioorg. Med. Chem. Lett. 19 2009 6119 6121
142. Y. Xiang, B. Hirth, Kane Jr, JL, J. Liao, K.D. Noson, C. Yee, G. Asmussen, M. Fitzgerald, C. Klaus, and M. Booker Discovery of novel sphingosine kinase-1 inhibitors. Part 2 Bioorg. Med. Chem. Lett 20 2010 4550 4554
143. T. Yamaji, and K. Hanada Sphingolipid metabolism and interorganellar transport: localization of sphingolipid enzymes and lipid transfer proteins Traffic 16 2015 101 122
144. R. Yamamoto, Y. Okada, J. Hirose, T. Koshika, Y. Kawato, M. Maeda, R. Saito, K. Hattori, H. Harada, Y. Nagasaka, and T. Morokata ASP4058, a novel agonist for sphingosine 1-phosphate receptors 1 and 5, ameliorates rodent experimental autoimmune encephalomyelitis with a favorable safety profile PLoS ONE 9 2014 e110819
145. Y. Yatomi, F. Ruan, T. Megidish, T. Toyokuni, S. Hakomori, and Y. Igarashi N,N-dimethylsphingosine inhibition of sphingosine kinase and sphingosine 1-phosphate activity in human platelets Biochemistry 35 1996 626 633
146. Y. Yoshimitsu, S. Oishi, J. Miyagaki, S. Inuki, H. Ohno, and N. Fujii Pachastrissamine (jaspine B) and its stereoisomers inhibit sphingosine kinases and atypical protein kinase C Bioorg. Med. Chem. 19 2011 5402 5408
147. Y. Zhang, V. Berka, A. Song, K. Sun, W. Wang, W. Zhang, C. Ning, C. Li, Q. Zhang, M. Bogdanov, D.C. Alexander, M.V. Milburn, M.H. Ahmed, H. Lin, M. Idowu, J. Zhang, G.J. Kato, O.Y. Abdulmalik, W. Zhang, W. Dowhan, R.E. Kellems, P. Zhang, J. Jin, M. Safo, A.L. Tsai, H.S. Juneja, and Y. Xia Elevated sphingosine-1-phosphate promotes sickling and sickle cell disease progression J. Clin. Invest. 124 2014 2750 2761